4 completed, 1 unknown. 5 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 5 | Completed 4, Unknown 1 |
Follow Primary Open-angle Glaucoma: new trials by email Literature Review of Primary Open-angle Glaucoma trials Research Report on Primary Open-angle Glaucoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study in Prostaglandin Associated Peri-orbitopathy Switching From Prostaglandin Monotherapy to Omidenepag Isopropyl Eybelis ophthalmic solution 0.002% - Normal Tension Glaucoma, Primary Open-angle Glaucoma | Phase 4 | Unknown | Santen Pharmaceutical Asia Pte. Ltd. | 150 | 2022-02-15 | 2022-03-15 |
| Peripapillary Blood Flow After Use of Anti-glaucoma Medications: An OCT Angiography Study Timolol Maleate, Brimonidine Tartrate - Glaucoma; Drugs, Normal Tension Glaucoma | Phase 4 | Completed | Wills Eye | 35 | 2017-07-10 | 2020-12-31 |
| Efficacy and Tolerability of an Innovative Formulation of BAK-free Latanoprost Latanoprost Ophthalmic Product - Primary Open-angle Glaucoma | Phase 4 | Completed | Laboratorios Poen | 103 | 2017-01-06 | 2017-11-08 |
| Efficacy and Tolerability of Preservative-free 0.0015% Tafluprost in Glaucoma Patients Benzalkonium chloride (BAK), 0.0015% tafluprost - Primary Open-angle Glaucoma | Phase 4 | Completed | Gangnam Severance Hospital | 20 | 2013-03-01 | 2017-04-07 |
| Study of Brinzolamide and Timolol When Added to Travoprost in Primary Open-angle Glaucoma or Ocular Hypertension Brinzolamide 1% added to Travoprost 0.004% - Primary Open-angle Glaucoma, Ocular Hypertension | Phase 4 | Completed | Alcon Research | 245 | 2004-02-01 | 2016-11-21 |
Glaucoma, Open-Angle (5) · Ocular Hypertension (3) · Glaucoma (2) · Low Tension Glaucoma (2)
Eye Diseases (5) · Glaucoma (3) · Ocular Hypertension (2) · Optic Nerve Diseases (2)
Benzalkonium Compounds (1) · Brimonidine Tartrate (1) · Timolol (1) · brinzolamide (1) · tafluprost (1)
Alcon Research (1) · Gangnam Severance Hospital (1) · Laboratorios Poen (1) · Santen Pharmaceutical Asia Pte. Ltd. (1) · Wills Eye (1)
Argentina (1) · Germany (1) · South Korea (1) · United States (1)
Alejo Peyret, PhD (1) · Anna Grau (1) · Daniel Grigera, PhD (1) · Daniel Lee, MD (1) · Gong Je Seong (1) · Javier Casiraghi, PhD (1) · Munseok Kook (1)